<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02562339</url>
  </required_header>
  <id_info>
    <org_study_id>2015P000956</org_study_id>
    <nct_id>NCT02562339</nct_id>
  </id_info>
  <brief_title>Resiliency Training for Adolescents With Craniofacial Conditions and Their Caregivers</brief_title>
  <official_title>Examining the Psychosocial Effects of Resiliency Training for Adolescents With Craniofacial Conditions and Their Caregivers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Foundation For Faces of Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective study that will examine psychosocial improvements among CF adolescents
      and caregivers going through the Stress Management and Resiliency Training - Relaxation
      Response Resiliency Program (SMART-3RP).
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Due to the departure of study staff and lack of interest by potential subjects and the sponsor,
    the investigators decided to end the study.
  </why_stopped>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Life (WHOQOL-BREF)</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>The WHOQOL-BREF comprises of 26 items which measure the following broad domains: physical health, psychological health, social relationships, and environment. The WHOQOL-BREF is a shorter version of the original instrument that may be more convenient for use in large research studies or clinical trials.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The 14-Item Resiliency Scale (RS-14)</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>The RS-14 measures stress coping ability in the face of adversity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with Life (SWL)</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>The Satisfaction with Life (SWL) scale is a reliable and valid 5-item self-report measure of global life satisfaction. Responses are made on a 7-point scale with higher scores reflecting higher life satisfaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived Stress Scale (PSS-10)</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>The PSS is a widely used psychological instrument for the measurement of the perception of stress. This 10-itam scale is designed to measure the degree to which situations in one's life are appraised, or considered stressful. The scores range from 0-40, with a higher score indicating higher perceived stress. Items were designed to detect how unpredictable, uncontrollable and overloaded respondents find their lives.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure of Current Status (MOCS-A)</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>The MOCS-A is a 13-item measure assessing participants' current self-perceived status on several skills such as: the ability to relax at will, recognize stress-inducing situations, restructure maladaptive thoughts, be assertive about needs, and choose appropriate coping responses as needed. Responses are made on a 7-point scale with higher scores reflecting higher life satisfaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire (PHQ) - caregivers only</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>The PHQ measures symptoms of depression and functional impairment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire for Adolescents (PHQ-A) - patients only</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>Symptoms of depression and functional impairment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generalized Anxiety Disorder 7-item (GAD-7)</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>A brief measure for assessing generalized anxiety disorder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive and Affective Mindfulness Scale (CAMS) - caregivers only</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>The CAMS measures the degree to which individuals experience their thoughts and feelings.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Child and Adolescent Mindfulness Measure (CAMM) - patients only</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>Assesses mindfulness in children and adolescents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interpersonal Reactivity Index (IRI)</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>The IRI assesses the cognitive and affective dimensions of empathy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distress Analogue Scales</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>The Distress Analogue Scales measure participants' levels of stress, coping, distress, and discomfort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Gratitude Questionnaire (GQ-6)</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>The GQ-6 revised is a 6-item measure that assesses individual differences in the proneness to experience gratitude in daily life. Scores range from 6-42, with a higher score indicating a greater sense of gratitude.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life Orientation Test (LOT) Optimism Scale</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>The LOT Optimism Scale measures individual differences in generalized optimism versus pessimism.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical Outcomes Study (MOS) Social Support Survey</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>The MOS Social Support Survey measures various dimensions of social support.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rosenberg Self Esteem Scale (RES)</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>Assesses levels of self esteem</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Body Image Quality of Life Inventory (BIQLI) - patients only</measure>
    <time_frame>Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)</time_frame>
    <description>Measures patients' perception of their own body image and how it relates to quality of life.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Age, Gender, Race, Ethnicity, Type of Craniofacial Condition, and Education Status of patients with craniofacial conditions and their caregivers</measure>
    <time_frame>Baseline (week 0)</time_frame>
    <description>This questionnaire asks patients/caregivers to report their age, gender, race, ethnicity, type of craniofacial condition, and highest level of education.</description>
  </other_outcome>
  <other_outcome>
    <measure>Expectancy Questionnaire</measure>
    <time_frame>Baseline (week 0)</time_frame>
    <description>Measures how much the participant believes the intervention will work</description>
  </other_outcome>
  <other_outcome>
    <measure>Intent to Attend Questionnaire</measure>
    <time_frame>Baseline (week 0)</time_frame>
    <description>On a scale from 1 [&quot;Not likely&quot; or &quot;Not motivated&quot;] to 3 [&quot;Very likely&quot; or &quot;Very motivated&quot;], participants are asked how likely and how motivated they are to attend the next session.</description>
  </other_outcome>
  <other_outcome>
    <measure>Participant Feedback - Program Satisfaction Questionnaire</measure>
    <time_frame>Post-intervention (week 8)</time_frame>
    <description>Measures how satisfied the participant is with the intervention</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Craniofacial Abnormalities</condition>
  <arm_group>
    <arm_group_label>SMART-3RP for Parents or Caregivers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive an 8-week behavioral intervention which teaches stress management and psychological resiliency-enhancing skills.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SMART-3RP for Adolescent Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive an 8-week behavioral intervention which teaches stress management and psychological resiliency-enhancing skills.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMART-3RP</intervention_name>
    <description>8-week group intervention teaching relaxation and psychological resiliency enhancing skills. Topics include the relaxation response, meditation, and yoga.</description>
    <arm_group_label>SMART-3RP for Parents or Caregivers</arm_group_label>
    <arm_group_label>SMART-3RP for Adolescent Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for Adolescent Patients:

          1. Adolescents aged 14 to 22

          2. English fluency and literacy

          3. Diagnosis of a craniofacial condition by self report

        Inclusion Criteria for Parents or Other Caregivers:

          1. Must be 18 years of age and older

          2. English fluency and literacy

          3. Parent or caregiver of a child or young adult with a craniofacial condition

        Exclusion Criteria:

          1. Unable to benefit from the program due to cognitive, psychiatric or other reasons
             based on the opinion of the group leader

          2. Unable or unwilling to sign the informed consent documents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John W. Denninger, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2015</study_first_submitted>
  <study_first_submitted_qc>September 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2015</study_first_posted>
  <last_update_submitted>June 24, 2016</last_update_submitted>
  <last_update_submitted_qc>June 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>John W. Denninger, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Craniofacial Abnormalities</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

